Regulation of Pharmaceuticals in Developing Nations: A Case from Nepal

  • Poudel B
  • Ishii I
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Department of Drug Administration (DDA), medicine regulatory authority of Nepal, is aligned towards achieving Universal Health Coverage through the regulation of medicines, pharmacies, manufacturing facilities and medicine testing laboratories from its offices located in Kathmandu, Birgunj, Biratnagar and Nepalgunj and takes legal or administrative actions as appropriate.  It has its own regulatory laboratory, National Medicines Laboratory for testing and analysis of medicines. Besides, DDA reports suspected ADR to Upshala Monitoring Centre, Sweden, provides drug information and conducts regulatory trainings. Unlike in the developed world, DDA may not be able to fulfill all of its objectives. But then, a mechanism of regulation of pharmaceuticals is functional and is dynamic as per national need.https://doi.org/10.21423/jrs-v04n04p018 (DOI assigned 5/14/2019)

Cite

CITATION STYLE

APA

Poudel, B. K., & Ishii, I. (2016). Regulation of Pharmaceuticals in Developing Nations: A Case from Nepal. Journal of Regulatory Science, 4(4), 18–20. https://doi.org/10.21423/jrs-v04n04p018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free